Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Dong-A PharmTech files IND for new PDE5 inhibitor for erectile dysfunction

April 1, 2005

Keryx finalizes SPA agreement for KRX-101

March 31, 2005

NX-1207 shows promise for BPH

March 29, 2005

PT-141 reported to increase the efficacy of sildenafil in ED

March 24, 2005

The STAR study confirms the greater efficacy of solifenacin in OAB

March 22, 2005

BXL-628 reduces prostate volume in patients with BPH

March 22, 2005

Galangin shows promise as a treatment for bladder dysfunction / News in Context

March 22, 2005

Antares Pharma files IND for oxybutynin ATD

March 21, 2005

ESR-1150-CL causes death in rats but not monkeys

March 15, 2005

Age and gender do not affect pharmacokinetics of solifenacin

March 14, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...